Prognostic Value of Delta Lymphocyte Index (DLIx) in Patients with Large B-Cell Lymphoma (LBCL) Treated with Chimeric Antigen Receptor (CAR) T-Cell Therapy

被引：0
|
作者：
Strati, Paolo
Mistry, Haleigh
Pulsifer, Brittany
Fayad, Luis
Ahmed, Sairah
Lee, Hun Ju
Iyer, Swami P.
Nair, Ranjit
Nastoupil, Loretta J.
Parmar, Simrit
Rodriguez, Maria Alma
Samaniego, Felipe
Raphael
Steiner, Eric
Wang, Michael
Pinnix, Chelsea C.
Dabaja, Bouthaina S.
Noorani, Mansoor
Claussen, Catherine M.
Shpall, Elizabeth J.
Kebriaei, Partow
Flowers, Chris R.
Westin, Jason R.
Neelapu, Sattva S.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-135846
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience
    Trando, Aaron
    Ter-Zakarian, Anna
    Yeung, Phillip
    Goodman, Aaron M.
    Hamdan, Ayad
    Hurley, Michael
    Jeong, Ah-Reum
    Tzachanis, Dimitrios
    CANCERS, 2023, 15 (18)
  • [2] ASSESSMENT OF UTILITIES FOR ADVERSE EVENTS (AES) ASSOCIATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA (LBCL)
    Howell, T.
    Matza, L.
    Jun, M. P.
    Garcia, J.
    Powers, A.
    Maloney, D. G.
    VALUE IN HEALTH, 2020, 23 : S39 - S39
  • [3] Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy
    Jallouk, Andrew P.
    Kui, Naishu
    Sun, Ryan
    Westin, Jason R.
    Steiner, Raphael E.
    Nair, Ranjit
    Nastoupil, Loretta J.
    Fayad, Luis E.
    Al Zaki, Ajlan
    Hawkins, Misha
    Adkins, Sherry
    Noorani, Mansoor
    Das, Kaberi
    Henderson, Jared
    Shpall, Elizabeth J.
    Kebriaei, Partow
    Ramdial, Jeremy
    Flowers, Christopher R.
    Neelapu, Sattva S.
    Ahmed, Sairah
    Strati, Paolo
    HAEMATOLOGICA, 2024, 109 (05) : 1460 - 1468
  • [4] Cytomegalovirus impact in b-cell lymphoma patients treated with chimeric antigen receptor t-cell therapy
    Marquez-Algaba, E.
    Pernas, B.
    Esperalba, J.
    Los-Arcos, I.
    Carpio, C.
    Iacoboni, G.
    Barba, P.
    Ruiz-Camps, I.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 134 - 134
  • [5] Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART)
    Greenbaum, Uri
    Hashmi, Hamza
    Elsawy, Mahmoud
    Kim, Soyoung
    Moskop, Amy
    Awan, Farrukh T.
    Farooq, Umar
    Ganguly, Siddhartha
    Hematti, Peiman
    Jain, Michael D.
    Kebriaei, Partow
    Locke, Frederick L.
    Mead, Elena
    Nishihori, Taiga
    Olson, Amanda L.
    Pennisi, Martina
    Perales, Miguel-Angel
    Geethakumari, Praveen Ramakrishnan
    Shouval, Roni
    Shpall, Elizabeth J.
    Magalhaes-Silverman, Margarida Magalhaes
    Strouse, Christopher
    Turtle, Cameron J.
    Vallurupalli, Anusha
    Wudhikam, Kitsada
    Pasquini, Marcelo C.
    Ahmed, Sairah
    Sorror, Mohamed
    BLOOD, 2022, 140 : 4636 - 4638
  • [6] Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Strati, Paolo
    Ahmed, Sairah
    Furqan, Fateeha
    Fayad, Luis E.
    Lee, Hun J.
    Iyer, Swaminathan P.
    Nair, Ranjit
    Nastoupil, Loretta J.
    Parmar, Simrit
    Rodriguez, Maria A.
    Samaniego, Felipe
    Steiner, Raphael E.
    Wang, Michael
    Pinnix, Chelsea C.
    Horowitz, Sandra B.
    Feng, Lei
    Sun, Ryan
    Claussen, Catherine M.
    Hawkins, Misha C.
    Johnson, Nicole A.
    Singh, Prachee
    Mistry, Haleigh
    Johncy, Swapna
    Adkins, Sherry
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Green, Michael R.
    Flowers, Christopher R.
    Westin, Jason
    Neelapu, Sattva S.
    BLOOD, 2021, 137 (23) : 3272 - 3276
  • [7] Efficacy of CD19 Directed Therapies in Large B-Cell Lymphoma (LBCL) Relapsing after Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Iqbal, Madiha
    Khurana, Arushi
    Chavez, Julio
    Rosenthal, Allison C.
    Li, Zhuo
    Craver, Emily
    Aditi, Saha
    Epperla, Narendranath
    Annunzio, Kaitlin
    Awan, Farrukh T.
    Isufi, Iris
    Dholaria, Bhagirathbhai
    Bhaskar, Shakthi
    Maakaron, Joseph
    Sumransub, Nuttavut
    Fijalka, Andrew
    Sandoval-Sus, Jose
    Ivanov, Stanislav
    Lin, Yi
    Kharfan-Dabaja, Mohamed A.
    BLOOD, 2022, 140 : 10396 - 10398
  • [8] Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma
    Ernst, Moritz
    Oeser, Annika
    Besiroglu, Burcu
    Caro-Valenzuela, Julia
    Aziz, Mohamed Abd El
    Monsef, Ina
    Borchmann, Peter
    Estcourt, Lise J.
    Skoetz, Nicole
    Goldkuhle, Marius
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (09):
  • [9] Chimeric Antigen Receptor T-Cell Therapy and Imaging Applications for Large B-Cell Lymphoma
    Mulholland, Nicola
    Chandra, Julie
    Sanderson, Robin
    Kuhnl, Andrea
    RADIOLOGY, 2023, 307 (05)
  • [10] Resistance Mechanisms Impacting Bispecific Antibody (BsAbs) and Chimeric Antigen Receptor (CAR) T-Cell Therapy Outcomes in Large B Cell Lymphoma (LBCL) Patients
    Iraola-Truchuelo, Josu
    Iacoboni, Gloria
    Palomo, Laura
    Navarro Garces, Victor
    Castellvi, Josep
    Mas, Alba
    Nonell, Lara
    Mayor, Luis A.
    Dourdil, Victoria
    Garcia Cerecedo, Tomas
    Lopez Godino, Oriana
    Sanchez-Salinas, Mario
    Carpio, Cecilia
    Crespo, Marta
    Serna, Angel
    Cabirta Touzon, Alba
    Bosch, Marc
    Garcia, Cristina
    Barba, Pere
    Bosch, Francesc
    Abrisqueta Costa, Pau
    BLOOD, 2023, 142
12345